Public-Private Partnership Helps Fund Superbug Fight
LIFE SCIENCES
Forge Therapeutics recently took in more funding — up to $11.1 million — to battle life-threatening infections called “superbugs.”
The San Diego biotech was awarded $5.7 million from Carb-X, a public-private partnership funding new antibiotic...
Read latest San Diego Business Journal online.
Online newspapers
at PressDisplay.